Skip to main content

Table 3 Univariable and multivariable Cox regression analysis for developing ASB within one year after transplantation according to TMP-SMX prophylaxis administration

From: The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study

  Outcome ASB P value
HR (95 % CI)
TMP-SMX: univariable model (a) 2.03 (1.17–3.55) 0.012
TMP-SMX: first multivariable model (b) 1.18 (0.63–2.20) 0.600
TMP-SMX: second multivariable model (c) 1.52 (0.79–2.94) 0.213
  1. a: Univariable model: adjusted for only TMP-SMX use
  2. b: First multivariable analysis: adjusted for diabetes mellitus, subtype of immunosuppressive therapy and indwelling urological catheters
  3. c: Second multivariable analysis: adjusted for diabetes mellitus, subtype of immunosuppressive therapy, indwelling urological catheters, age of recipient and donor and female gender